Fine Organic (FINEORG)

FairStock Score: 49/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Fine Organic as a specialty chemicals business and ask whether its numbers reveal a moat. The balance sheet is a standout: debt/equity of 0.03 means it barely leans on borrowed money, and ROCE of 26.39% tells me the capital employed is working hard. Promoter holding at 75.00% aligns owners with shareholders. Growth is respectable: sales up 14.19%, profit up 45.94%, and five-year revenue CAGR of 16.93%. Latest quarter sales ₹555 Cr and net profit ₹74 Cr show profitability, but I need to know whether margins are durable. At ₹5143.80, market cap ₹15,771 Cr, P/E 35.97, P/B 5.92, and PEG 5.03, Mr. Market is already paying for much of the good news. The 52-week range of ₹3856.00–₹5661.95 shows the stock has run hard, so Graham's margin of safety is thin here. A 16.89% ROE is decent but not exceptional for a P/B near 6. The negative free cash flow of ₹-472 Cr is a yellow flag: profits are not yet converting into owner cash. Dividend yield is only 0.21%, so most return depends on price appreciation. The Piotroski F-Score of 4/9 and FairStock 49/100 reinforce a mixed picture. I like the low debt and ROCE, but I would not chase at this valuation. I'd wait for a wider discount, stronger FCF, and evidence that growth continues without balance-sheet stress. This is a good business, but not a bargain today.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer